Cargando…
Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19
The first confirmed case of novel Coronavirus Disease 2019 (COVID-19) in the United States was reported on January 20, 2020. As of November 24, 2020, close to 12.2 million cases of COVID-19 was confirmed in the US, with over 255,958 deaths. The rapid transmission of Severe Acute Respiratory Syndrome...
Autores principales: | Hamouche, Walid, Bisserier, Malik, Brojakowska, Agnieszka, Eskandari, Abrisham, Fish, Kenneth, Goukassian, David A., Hadri, Lahouaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833205/ https://www.ncbi.nlm.nih.gov/pubmed/33373644 http://dx.doi.org/10.1016/j.yjmcc.2020.12.009 |
Ejemplares similares
-
Retrospective analysis of demographic factors in COVID-19 patients entering the Mount Sinai Health System
por: Eskandari, Abrisham, et al.
Publicado: (2021) -
Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients
por: Brojakowska, Agnieszka, et al.
Publicado: (2021) -
Lung-targeted SERCA2a Gene Therapy: From Discovery to Therapeutic Application in Bleomycin-Induced Pulmonary Fibrosis
por: Bisserier, Malik, et al.
Publicado: (2020) -
Long-Term Effects of Very Low Dose Particle Radiation on Gene Expression in the Heart: Degenerative Disease Risks
por: Garikipati, Venkata Naga Srikanth, et al.
Publicado: (2021) -
Current and emerging therapeutic approaches to pulmonary hypertension
por: Bisserier, Malik, et al.
Publicado: (2020)